Literature DB >> 29369078

Thromboelastographic study of the snakebite-related coagulopathy in Djibouti.

Sébastien Larréché1, François-Xavier Jean2, Alain Benois3, Aurélie Mayet4, Aurore Bousquet1, Serge Vedy5, Patrick Clapson3, Céline Dehan5, Christophe Rapp6, Eric Kaiser3, Audrey Mérens1, Georges Mion7, Christophe Martinaud8.   

Abstract

: Hemostasis disorders are one of the major clinical conditions of snakebites and are because of mechanisms which may disrupt vessels, platelets, clotting factors and fibrinolysis. Thromboelastography (TEG) could help to understand these effects in the clinical practice. A retrospective study reports a series of patients presenting a snakebite-related coagulopathy, treated with antivenom and monitored with conventional tests and TEG in a French military treatment facility (Republic of Djibouti, East Africa) between August 2011 and September 2013. Conventional coagulation assays (platelets, prothrombin time, activated partial thromboplastin time, fibrinogen) and TEG measurements were taken on arrival and at various times during the first 72 h of hospitalization, at the discretion of the physician. The study included 14 patients (median age 28 years). Bleedings were present in five patients. All patients received antivenom. A coagulopathy was present in all patients and was detected by both conventional assays and TEG. None exhibited thrombocytopenia. Prothrombin time and fibrinogen remained abnormal for most of patients during the first 72 h. The TEG profiles of 11 patients (79%) showed incoagulability at admission (R-time > 60 min). TEG distinguished 10 patients with a generalized clotting factor deficiency and 4 patients with an isolated fibrinogen deficiency after an initial profile of incoagulability. Hyperfibrinolysis was evident for 12 patients (86%) after Hour 6. Snake envenomations in Djibouti involve a consumption coagulopathy in conjunction with delayed hyperfibrinolysis. TEG could improve medical management of the condition and assessment of additional therapeutics associated with the antivenom.

Entities:  

Mesh:

Year:  2018        PMID: 29369078     DOI: 10.1097/MBC.0000000000000702

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

1.  Thromboelastography with Platelet Studies (TEG® with PlateletMapping®) After Rattlesnake Envenomation in the Southwestern United States Demonstrates Inhibition of ADP-Induced Platelet Activation As Well As Clot Lysis.

Authors:  A Min Kang; Erik S Fisher
Journal:  J Med Toxicol       Date:  2019-08-12

2.  Case Report: Rotational Thromboelastometry in Taipan Envenomation.

Authors:  Catherine L Tacon; Azhar Munas; Mark Little
Journal:  Am J Trop Med Hyg       Date:  2021-11-01       Impact factor: 2.345

Review 3.  Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite.

Authors:  Tommaso C Bulfone; Stephen P Samuel; Philip E Bickler; Matthew R Lewin
Journal:  J Trop Med       Date:  2018-07-30

4.  Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial.

Authors:  Julien Potet; James Smith; Lachlan McIver
Journal:  PLoS Negl Trop Dis       Date:  2019-06-24

5.  Correlations between rotational thromboelastometry (ROTEM) and standard coagulation tests following viper snakebites.

Authors:  Xuan Thi Dang; Thanh Xuan Nguyen; Huong Thi Thu Nguyen; Hung Tran Ha
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

6.  Hemostatic Analysis of Simulated Gloydius ussuriensis Envenomation Using Canine Blood: A Comparison of Thromboelastography and Classical Coagulation Tests.

Authors:  Jong-Sun Lee; Jung-Hyun Kim
Journal:  Animals (Basel)       Date:  2022-01-18       Impact factor: 2.752

7.  Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs from Lethal Doses of Micrurus fulvius (Eastern Coral Snake) Venom.

Authors:  Matthew R Lewin; Lyndi L Gilliam; John Gilliam; Stephen P Samuel; Tommaso C Bulfone; Philip E Bickler; José María Gutiérrez
Journal:  Toxins (Basel)       Date:  2018-11-17       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.